Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Eli Lilly CEO David Ricks, whose company has a coronavirus treatment in Phase 3 of clinical trials, told "Axios on HBO" that it'd be smart to share with other countries rather than going America first.

The big picture: 66% of Americans don't want to share a vaccine right away with the rest of the world if the U.S. gets there first, according to a recent Harris poll, Axios' Sam Baker reported last week.

  • Ricks, incoming chair of the industry group PhRMA, told Mike Allen the goal would be to "protect as much of the planet as we can, versus looking after only one country by itself — creating an island, which would be, I think, illusory."

But Ricks made a 2-part case for why that is shortsighted.

  • Reason 1: "[I]f an individual country exceeds, let's say there's a category of people ... that have the highest risk and we vaccinate all of them. Should we go to the next category of risk or share it with others who have that same, I think humanitarian principles would say we should share at that point."
  • Reason 2: "[W]e have to recognize back to the point on public health that this is a shared risk, not an individual risk. So if in an imaginary world we had protected our risk groups A, B and C, but no one else had protected any of theirs, meaning other countries, we still run the risk of people traveling to the US and infecting more and more people.

Between the lines: Ricks noted that the FDA is using a "low bar" for evaluating COVID-19 vaccines, which he defended as "probably appropriate" because of the urgency of the pandemic.

  • "[T]he FDA standard ... for vaccine effectiveness is a 50 percent response, meaning that half the people have an adequate response to retain antibodies and mount their own immune response to the disease without getting sick initially."

The bottom line: "I think the strongest global interest is to vaccinate as many high risk people as possible," Ricks said.

Go deeper

Dec 9, 2020 - Health

Pfizer-BioNTech vaccine data hacked from European Medicines Agency breach

A nurse in London prepares a dose of Pfizer-BioNTech's COVID-19 vaccine on Dec. 8. Photo: Frank Augstein/POOL/AFP via Getty Images

BioNTech and Pfizer announced Wednesday the European Medicines Agency was targeted by a cyberattack and regulatory documents related to their coronavirus vaccine submission were accessed.

Why it matters: The EMA is currently working to authorize coronavirus vaccines for use in European Union member states, and said it is launching an investigation into the attack. The hack is the latest in a series of attacks and warnings about cyber threats against vaccine-producers and public health agencies.

Dec 9, 2020 - Health

Pennsylvania governor tests positive for coronavirus

Gov. Tom Wolf at a press conference on Oct. 1. Photo: Pete Bannan/MediaNews Group/Daily Local News via Getty Images

Pennsylvania Gov. Tom Wolf (D), 72, tested positive for COVID-19 on Tuesday, and is experiencing no symptoms as he self-isolates, he tweeted Wednesday.

The big picture: Current coronavirus hospitalizations and cases are skyrocketing in Pennsylvania, as well as in many states across the U.S., per the COVID Tracking Project. Wolf tweeted on Tuesday that "hospitalizations are reaching critical levels" in his state.

Firefighters end search for bodies at Surfside

A picture in the memorial that has photographs of some of the victims from the partially collapsed 12-story Champlain Towers South condo building on July 15 in Surfside, Florida. Photo by Joe Raedle/Getty Images

Firefighters on Friday concluded their search for bodies at the site of the June 24 collapse of the Champlain Towers South condominium in Surfside, Florida.

Driving the news: 97 people were killed and one woman, Estelle Hedaya, remains missing.